MG-T004

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMG-T004
Drug Alias NameMG-T004H4B-121
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonistsAnticancer protein kinase inhibitors
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsDiabetes MellitusNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMilleGen SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMilleGen SASmartmAbs
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A